Glenn E. Wright

Glenn Wright has a diverse and extensive work experience spanning several companies and roles. Glenn is currently the President & CEO of PDA - Parenteral Drug Association, a position they have held since March 2023. Prior to that, they served as the Chief Operating Officer of PDA from April 2022 to March 2023. Glenn also held the position of Vice President of Scientific and Regulatory Affairs at PDA from March 2020 to April 2022.

In addition to their work at PDA, Glenn has held various roles at other organizations. Glenn served as the Chairman Of The Board at Product Quality Research Institute starting from March 2021. Prior to that, they were the Sr. Director Quality Operations at Exelead from July 2018 to January 2020. Glenn also worked as a Business Development Fellow at PDA from January 2018 to May 2018.

Before their current roles, Glenn had a long and successful career at Eli Lilly and Company. Glenn held several positions, including Sr. Director/Adviser, Technical Services/Manufacturing Science - Retired, Diversity and Inclusion Leader, Sr. Director Quality Eli Lilly Italia (Site Quality Head), Director Manufacturing Science and Technology, Director Global Regulatory Affairs, Manager QC Development, and Corporate Auditor.

Glenn's career also includes roles at PDA, where they served on the Board of Directors from January 2011 to December 2016 and from January 1998 to December 2003. Glenn has also worked at Amgen as a Corporate Auditor and QA/QC Microbiology Lab Operations Head. Glenn started their career at Pfizer as a Staff Microbiologist.

Overall, Glenn Wright has a wealth of experience in the pharmaceutical industry, with expertise in areas such as quality operations, regulatory affairs, and technical services.

Glenn Wright pursued their education from 1982 to 1988 at Southern Illinois University, Carbondale. During this period, they earned their Bachelor of Science (BS) and Masters of Science (MS) degrees in the field of Microbiology.